From Asymptomatic to Symptomatic: a Cause of Nosebleed - Fatal Forty DDI: warfarin, amiodarone, CYP2C9 (CROSBI ID 48528)
Prilog u knjizi | izvorni znanstveni rad
Podaci o odgovornosti
Markić, Joško ; Meštrović, Julije ; Sprung, Juraj
engleski
From Asymptomatic to Symptomatic: a Cause of Nosebleed - Fatal Forty DDI: warfarin, amiodarone, CYP2C9
This case discusses amiodarone added to warfarin. Amiodarone is a cytochrome P450 2C9 inhibitor and the more actively anticoagulant S-enantiomer of warfarin is a 2C9 substrate. The interaction results in an enhanced anticoagulant effect.
interaction, warfarin, amiodarone, CYP2C9
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
669-673.
objavljeno
Podaci o knjizi
A Case Approach to Perioperative Drug-Drug Interactions
Marcucci, C ; Hutchens, MP ; Wittwer, ED ; Weingarten, TN ; Sprung, J ; et al.
New York (NY): Springer
2015.
978-1-4614-7494-4